CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 34 of 48

Rheumatology (Oxford)

Briefs 1,321–1,360 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    A real-world 2-year prospective study of medication tapering in patients with well-controlled rheumatoid arthritis within the rheumatoid arthritis medication tapering (RHEUMTAP) cohort

    Cohort studyRA

  2. Rheumatology (Oxford)

    Patient perspectives on tapering biologic or targeted synthetic therapy in well-controlled rheumatoid arthritis and comparison with providers’ perspectives

    Cross-sectional studyRA

  3. Rheumatology (Oxford)

    A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry

    Cohort studyPediatric

  4. Rheumatology (Oxford)

    Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors

    Cohort studyRA

  5. Rheumatology (Oxford)

    Prognostic value and predictors of the alteration of the diffusing capacity of the lungs for carbon monoxide in systemic lupus erythematosus

    Cohort studyLupus & APS

  6. Rheumatology (Oxford)

    Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis

    Meta-analysisRA

  7. Rheumatology (Oxford)

    Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method

    Cross-sectional studyVasculitis & PMR

  8. Rheumatology (Oxford)

    Correlation between B-cell epitope profile and clinical features of anti-MDA5 antibody-positive dermatomyositis

    Cross-sectional studyMyositis

  9. Rheumatology (Oxford)

    Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis

    Cohort studyRA

  10. Rheumatology (Oxford)

    Comparison of patients with biopsy positive and negative primary angiitis of the central nervous system

    Cohort studyVasculitis & PMR

  11. Rheumatology (Oxford)

    N-terminal pro-brain natriuretic peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study

    Cross-sectional studyLupus & APS

  12. Rheumatology (Oxford)

    Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities

    Cohort studyMyositis

  13. Rheumatology (Oxford)

    Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population

    Cohort studyRA

  14. Rheumatology (Oxford)

    Subcutaneous immunoglobulin for patients with idiopathic inflammatory myopathies: a real-world, single-centre experience

    Cohort studyMyositis

  15. Rheumatology (Oxford)

    Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study

    Cohort studySpondyloarthritis & PsA

  16. Rheumatology (Oxford)

    Trends of disease activity in Japanese patients over 75 years with rheumatoid arthritis from 2014 to 2021: the ANSWER cohort study

    Cohort studyRA

  17. Rheumatology (Oxford)

    Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?

    Cohort studyRA

  18. Rheumatology (Oxford)

    The risk of cardiovascular comorbidity in children with Behçet’s disease

    Cross-sectional studyPediatric

  19. Rheumatology (Oxford)

    Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation

    Cross-sectional studyLupus & APS

  20. Rheumatology (Oxford)

    Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases

    Cohort studyRA

  21. Rheumatology (Oxford)

    Addressing the unmet needs of transitional care in juvenile idiopathic arthritis

    Research articlePediatric

  22. Rheumatology (Oxford)

    Effects of oral contraceptives and menopausal hormone therapy on the risk of rheumatoid arthritis: a prospective cohort study

    Cohort studyRA

  23. Rheumatology (Oxford)

    Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis

    Cross-sectional studySystemic sclerosis

  24. Rheumatology (Oxford)

    Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study

    Cohort studyAutoinflammatory & rare

  25. Rheumatology (Oxford)

    Patient factors and health outcomes associated with illness perceptions in people with gout

    Secondary analysisGout & crystals

  26. Rheumatology (Oxford)

    Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis

    Meta-analysisAutoinflammatory & rare

  27. Rheumatology (Oxford)

    Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999–2022

    Cohort studyLupus & APS

  28. Rheumatology (Oxford)

    Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?

    Cohort studyRA

  29. Rheumatology (Oxford)

    Digital artery reconstruction with interposition vein graft: impact on secondary Raynaud’s phenomenon

    Cohort studySystemic sclerosis

  30. Rheumatology (Oxford)

    Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden

    Cross-sectional studyVasculitis & PMR

  31. Rheumatology (Oxford)

    The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still’s disease

    Mechanistic studyAutoinflammatory & rare

  32. Rheumatology (Oxford)

    Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial

    Cross-sectional studyRA

  33. Rheumatology (Oxford)

    Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study

    Cross-sectional studySpondyloarthritis & PsA

  34. Rheumatology (Oxford)

    Paraneoplastic arthritis: a series of 92 cases

    Cohort studyAcross diseases

  35. Rheumatology (Oxford)

    Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey

    Cohort studyAutoinflammatory & rare

  36. Rheumatology (Oxford)

    Effect of smoking on thrombotic antiphospholipid syndrome: a 10-year prospective cohort study

    Cohort studyLupus & APS

  37. Rheumatology (Oxford)

    Reproductive health in female patients with systemic sclerosis: a cross-sectional study

    Cross-sectional studySystemic sclerosis

  38. Rheumatology (Oxford)

    Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

    Cohort studySpondyloarthritis & PsA

  39. Rheumatology (Oxford)

    Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry

    Cohort studyPediatric

  40. Rheumatology (Oxford)

    Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

    Cohort studyRA

All 1,905 Briefs in ExploreShowing Briefs 1,321–1,360 of 1,905, newest first